ISIN | LU2488092649 |
---|---|
Valor Number | 119403766 |
Bloomberg Global ID | |
Fund Name | Kieger Sustainable Healthcare Fund Class B EUR Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
Peculiarities |
Current Price * | 98.78 EUR | 10.09.2025 |
---|---|---|
Previous Price * | 99.83 EUR | 09.09.2025 |
52 Week High * | 119.54 EUR | 05.02.2025 |
52 Week Low * | 93.66 EUR | 07.08.2025 |
NAV * | 98.78 EUR | 10.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 161,490,174 | |
Unit/Share Assets *** | 135,621 | |
Trading Information SIX |
YTD Performance | -10.87% |
31.12.2024 - 10.09.2025
31.12.2024 10.09.2025 |
---|---|---|
YTD Performance (in CHF) | -11.37% |
31.12.2024 - 10.09.2025
31.12.2024 10.09.2025 |
1 month | +4.68% |
11.08.2025 - 10.09.2025
11.08.2025 10.09.2025 |
3 months | -3.90% |
10.06.2025 - 10.09.2025
10.06.2025 10.09.2025 |
6 months | -11.56% |
10.03.2025 - 10.09.2025
10.03.2025 10.09.2025 |
1 year | -15.92% |
10.09.2024 - 10.09.2025
10.09.2024 10.09.2025 |
2 years | -2.97% |
11.09.2023 - 10.09.2025
11.09.2023 10.09.2025 |
3 years | -1.22% |
06.07.2023 - 10.09.2025
06.07.2023 10.09.2025 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 5.81% | |
---|---|---|
Novartis AG Registered Shares | 5.68% | |
Abbott Laboratories | 5.32% | |
AstraZeneca PLC | 4.82% | |
Roche Holding AG | 4.81% | |
Vertex Pharmaceuticals Inc | 4.07% | |
Novo Nordisk AS Class B | 4.05% | |
UnitedHealth Group Inc | 4.03% | |
Boston Scientific Corp | 3.96% | |
Intuitive Surgical Inc | 3.61% | |
Last data update | 30.06.2025 |
TER *** | 0.99% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |